SC 13G

Company

Tevogen Bio Holdings Inc.

Filed

January 22, 2024

Accession Number

0001193125-24-011610

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →